CD274 and neoplasm: As a well‐known immune checkpoint, although the clinical efficacy of PD‐L1 blocking in PC has been observed, PD‐1/PD‐L1 inhibitors enable T lymphocytes to restore the killing function to tumor cells by removing the immunosuppressive regulation of T lymphocytes [72].